SEC 13F Intelligence

Lion Point Capital, LP / BNTC

Lion Point Capital, LP’s Benitec Biopharma Inc Position

Does Lion Point Capital, LP own Benitec Biopharma Inc (BNTC)? Yes — 62.0K shares worth $660,300 (+3.95% of its 13F portfolio) as of Q1 2026.

Position Value
$660,300
Q1 2026
Shares
62.0K
% of Portfolio
+3.95%
Quarters Held
7
currently held

Position History BNTC

Reported value by quarter
Q3 ’24: $358,410Q3 ’24Q4 ’24: $783,060Q4 ’24Q1 ’25: $806,620Q1 ’25Q2 ’25: $725,400Q2 ’25Q3 ’25: $869,860Q3 ’25Q4 ’25: $835,140Q4 ’25Q1 ’26: $660,300Q1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202662.0K$660,300+3.95%
Q4 202562.0K$835,140+4.32%
Q3 202562.0K$869,860+4.94%
Q2 202562.0K$725,400+4.93%
Q1 202562.0K$806,620+5.15%
Q4 202462.0K$783,060+4.10%
Q3 202439.0K$358,410+0.80%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of BNTC.